Sun Pharmaceutical Industries Limited (BOM:524715)
1,758.00
-2.00 (-0.11%)
At close: Oct 28, 2026
BOM:524715 Market Cap
BOM:524715 has a market cap or net worth of 4.22 trillion as of October 28, 2026. Its market cap has increased by 3.77% in one year.
Market Cap
4.22T
Enterprise Value
3.93T
Revenue
599.11B
Global Rank
n/a
Country Rank
n/a
PE Ratio
34.88
ChartMarket Cap Chart
Since February 15, 2001, BOM:524715's market cap has increased from 27.61B to 4.22T, an increase of 15,172.46%. That is a compound annual growth rate of 21.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 4.22T | 2.20% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.22T |
| Divi's Laboratories | 2.54T |
| Laurus Labs | 1.18T |
| Zydus Lifesciences | 1.17T |
| Cipla | 1.10T |
| Mankind Pharma | 1.03T |
| Aurobindo Pharma | 946.38B |
| Glenmark Pharmaceuticals | 649.06B |